MedHab, LLC. to Present on Smart Insole Tracking System at the 7th International PETRA Conference

FORT WORTH, Texas, May 13, 2014 /PRNewswire/ -- MedHab, LLC., a privately held athletic and medical device company focused on the development of unique rehabilitative and sport-enhancing tools, announced today that Johnny Ross, President and Chief Executive Officer of MedHab and inventor of RPM², will be presenting and delivering a product demonstration during the 7^th International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) on May 27 - 30, 2014, at the Hotel Aldemar Paradise Mare in Rhodes Island, Greece.

"We're delighted to have an opportunity to present RPM² for the first time during PETRA," said Johnny Ross, president and CEO of MedHab and inventor of RPM². "Given the science behind RPM², we believe athletes that utilize this device will have a significant advantage in optimizing their performance, and patients undergoing physical therapy may recover more quickly." 

The presentation, titled, "Development of a Smart Insole Tracking System for Physical Therapy and Athletes," will discuss MedHab's remote technology, found in the company's RPM² and StepRite devices, and how it assists healthcare professionals efficiently develop personalized physical therapy programs for their patients. The presentation will be in Room 1 on May 29^th at 9:00 a.m. EEST during the "Usability and HCI Issues" session.

Following the presentation, Mr. Ross will provide a product demonstration of the smart insole tracking system, in Room 2 between 2:00 p.m. – 4:00 p.m. EEST during the "Healthcare and Industrial Innovations in Assistive Technologies" session. Mr. Ross will discuss how the device provides detailed measurements of the lower extremities and provides actionable and personalized feedback on a patient's gait, range of motion and pressure distribution so bilateral deficiencies can be identified, corrected and optimized.

The wireless smart insole tracking system technology was originally developed for MedHab's StepRite device to remotely monitor patients undergoing physical therapy for leg injuries. StepRite provides healthcare professionals a way to customize physical rehabilitation protocols to meet each patient's unique need, while minimizing imbalances and the overall risk of future injuries.

The remote monitoring, pressure sensing foot-bed device was further enhanced to develop RPM², which has undergone extensive validity testing using today's clinical standards in gait analysis at Texas A&M University Corpus Christi. By maximizing bilateral equivalency, RPM² provides athletes with a competitive edge by correcting improper mechanics, increasing performance and preventing injury.

Bilateral deficiency is marked by differentiating levels of strength between two sides of the body, which can lead to imbalance, injuries and muscle strains that negatively impact athletic performance and rehabilitation efforts. Because of the significant expertise and costs associated with examining this aspect of training, gait analysis is often overlooked. Bilateral deficiencies in patients and athletes can continue progressing during rehabilitation and strength training, respectively, until injury occurs. By proactively addressing this issue, patients and athletes can reverse imbalances and prevent future injuries.

About RPM²

RPM² was developed from technology intended to remotely monitor patients undergoing physical therapy.  Johnny Ross, inventor of RPM², underwent major reconstructive knee surgery and was tasked with performing seemingly outdated methods of rehab, inspiring the invention of this product as a preventative and athletic-enhancing device.  RPM² has undergone extensive validity testing using today's clinical standards in gait analysis at Texas A&M University Corpus Christi, and provides athletes with a competitive edge by helping correct improper mechanics, increase performance and prevent injury, ultimately maximizing bilateral equivalence/symmetry.

For Media:
Tiberend Strategic Advisors, Inc.
Andrew Mielach
[email protected]; (212) 375-2694

SOURCE MedHab, LLC.